Personal tools

MCL coexpression mm9:1874: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0001017!4.08e-33!73;UBERON:0001016!7.52e-32!75;UBERON:0002346!1.96e-30!64;UBERON:0003075!1.96e-30!64;UBERON:0007284!1.96e-30!64;UBERON:0004121!1.17e-29!95;UBERON:0000924!1.17e-29!95;UBERON:0006601!1.17e-29!95;UBERON:0000073!1.94e-28!54;UBERON:0001049!2.23e-27!52;UBERON:0005068!2.23e-27!52;UBERON:0006241!2.23e-27!52;UBERON:0007135!2.23e-27!52;UBERON:0010371!3.78e-26!73;UBERON:0000955!1.36e-25!47;UBERON:0006238!1.36e-25!47;UBERON:0003056!4.21e-25!49;UBERON:0002616!7.39e-25!46;UBERON:0010314!1.19e-22!92;UBERON:0003080!8.29e-22!40;UBERON:0002780!4.15e-21!39;UBERON:0001890!4.15e-21!39;UBERON:0006240!4.15e-21!39;UBERON:0002020!1.09e-17!34;UBERON:0003528!7.20e-16!29;UBERON:0002791!7.20e-16!29;UBERON:0001893!7.20e-16!29;UBERON:0000956!1.66e-11!21;UBERON:0001869!1.66e-11!21;UBERON:0000203!1.66e-11!21;UBERON:0002619!5.60e-10!17;UBERON:0000025!9.98e-10!114;UBERON:0004111!1.62e-09!122;UBERON:0002021!3.19e-07!10;UBERON:0000411!3.19e-07!10;UBERON:0001950!3.19e-07!10
|ontology_enrichment_uberon=UBERON:0001017!4.08e-33!73;UBERON:0001016!7.52e-32!75;UBERON:0002346!1.96e-30!64;UBERON:0003075!1.96e-30!64;UBERON:0007284!1.96e-30!64;UBERON:0004121!1.17e-29!95;UBERON:0000924!1.17e-29!95;UBERON:0006601!1.17e-29!95;UBERON:0000073!1.94e-28!54;UBERON:0001049!2.23e-27!52;UBERON:0005068!2.23e-27!52;UBERON:0006241!2.23e-27!52;UBERON:0007135!2.23e-27!52;UBERON:0010371!3.78e-26!73;UBERON:0000955!1.36e-25!47;UBERON:0006238!1.36e-25!47;UBERON:0003056!4.21e-25!49;UBERON:0002616!7.39e-25!46;UBERON:0010314!1.19e-22!92;UBERON:0003080!8.29e-22!40;UBERON:0002780!4.15e-21!39;UBERON:0001890!4.15e-21!39;UBERON:0006240!4.15e-21!39;UBERON:0002020!1.09e-17!34;UBERON:0003528!7.20e-16!29;UBERON:0002791!7.20e-16!29;UBERON:0001893!7.20e-16!29;UBERON:0000956!1.66e-11!21;UBERON:0001869!1.66e-11!21;UBERON:0000203!1.66e-11!21;UBERON:0002619!5.60e-10!17;UBERON:0000025!9.98e-10!114;UBERON:0004111!1.62e-09!122;UBERON:0002021!3.19e-07!10;UBERON:0000411!3.19e-07!10;UBERON:0001950!3.19e-07!10
|tfbs_overrepresentation_for_novel_motifs=0.641384,0.128156,0.612053,0.688265,0.483253,0.704257,0.803568,0.370124,0.381467,0.489964,0.755749,0.790506,0.37041,0.81685,0.502646,0,1.02248,0.473993,0.352304,0.24402,0.570433,0.57409,0.815872,0.481455,0.620553,0.846564,0.342316,0.727368,0.535752,0.290745,0.711848,1.12823,0.471365,0.854272,0.503207,0.089443,0.460474,0.786577,0.434783,0.40068,0.478558,0.717547,0.185353,0.504971,0.66772,0.675898,0.938241,0.744678,0.162985,0.539131,1.0041,0.875451,0.771943,1.2746,1.29252,0.82458,0.549352,0.776619,0.331485,0.822375,1.10737,0.885556,0.39557,0.992216,0.8366,1.03484,1.43193,1.78579,1.1025,1.63712,0.590754,0.98374,0.205546,1.32691,0.864765,0.310084,0.318792,0.926147,1.08947,0.575233,0.37865,1.04072,0.884013,0.362446,1.20828,0.11855,0.129654,0.290918,0.943446,1.94914,1.50286,1.21342,1.14153,0.490141,0.430015,0.409166,0.367176,1.14445,0.938512,0.264911,1.16494,1.12793,1.25667,1.00472,1.00361,0.717061,1.06633,0.740267,0.580757,0.57247,0.633483,1.25851,0.576517,0.7614,1.51002,0.476467,0.869142,0.692434,1.02384,0.456123,1.33244,0.970073,0.848526,0.925183,1.56496,1.09333,0.812403,1.13449,1.43038,0.493609,1.23918,0.680176,1.40022,0.839311,1.53196,0.195549,0.650785,0.719099,1.482,2.31884,1.91709,1.43673,0.861473,1.1391,0.996781,0.718046,0.941555,2.27909,0.653418,0.485304,0.293812,0.184289,1.27621,0.416214,0.838313,1.35996,0.87653,0.516549,0.63863,0.650472,1.49167,1.20739,1.09379,0.630949,0.993294,0.830321,2.02497,0.788782,0.280875
}}
}}

Revision as of 20:33, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:126632769..126632795,-p1@Dtx3
Mm9::chr19:4906598..4906632,-p1@Bbs1
Mm9::chr2:91284786..91284883,-p1@1110051M20Rik
Mm9::chr4:151852285..151852292,+p3@Nphp4


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0001895retinal homeostasis0.0150643656558385
GO:0035058sensory cilium biogenesis0.0150643656558385
GO:0042384cilium biogenesis0.0281132154888067
GO:0001894tissue homeostasis0.0313158528520386
GO:0048871multicellular organismal homeostasis0.0313158528520386
GO:0016358dendrite development0.0376144828755884
GO:0030031cell projection biogenesis0.0376144828755884
GO:0007219Notch signaling pathway0.0376144828755884
GO:0000226microtubule cytoskeleton organization and biogenesis0.0427804872174396



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
central nervous system4.08e-3373
nervous system7.52e-3275
neurectoderm1.96e-3064
neural plate1.96e-3064
presumptive neural plate1.96e-3064
ectoderm-derived structure1.17e-2995
ectoderm1.17e-2995
presumptive ectoderm1.17e-2995
regional part of nervous system1.94e-2854
neural tube2.23e-2752
neural rod2.23e-2752
future spinal cord2.23e-2752
neural keel2.23e-2752
ecto-epithelium3.78e-2673
brain1.36e-2547
future brain1.36e-2547
pre-chordal neural plate4.21e-2549
regional part of brain7.39e-2546
structure with developmental contribution from neural crest1.19e-2292
anterior neural tube8.29e-2240
regional part of forebrain4.15e-2139
forebrain4.15e-2139
future forebrain4.15e-2139
gray matter1.09e-1734
brain grey matter7.20e-1629
regional part of telencephalon7.20e-1629
telencephalon7.20e-1629
cerebral cortex1.66e-1121
cerebral hemisphere1.66e-1121
pallium1.66e-1121
regional part of cerebral cortex5.60e-1017
tube9.98e-10114
anatomical conduit1.62e-09122
occipital lobe3.19e-0710
visual cortex3.19e-0710
neocortex3.19e-0710


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}